<!DOCTYPE html>
<html lang="en-GB">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ASX Announcements - 1 August 2025</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
    <style>
        :root {
            --primary-color: #000000;
            --secondary-color: #333333;
            --accent-color: #666666;
            --text-color: #000000;
            --light-bg: #f5f5f5;
            --card-bg: #ffffff;
            --border-color: #e0e0e0;
            --box-shadow: 0 2px 4px rgba(0,0,0,0.1);
            --box-shadow-hover: 0 4px 12px rgba(0,0,0,0.15);
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body { 
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            background: var(--light-bg);
            color: var(--text-color);
            line-height: 1.6;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 2rem;
        }
        
        /* Card base styles */
        .header,
        .summary-card,
        .filter,
        .footer,
        .no-data { 
            background: var(--card-bg);
            border-radius: 8px;
            box-shadow: var(--box-shadow);
        }
        
        .header { 
            padding: 2rem; 
            margin-bottom: 2rem; 
            text-align: center;
        }
        
        .header h1 { 
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: var(--primary-color);
        }
        
        .meta { 
            color: var(--accent-color); 
            font-size: 1.1rem;
            display: flex;
            align-items: center;
            justify-content: center;
            gap: 1rem;
            margin-top: 1rem;
        }
        
        .summary-grid {
            display: grid;
            gap: 1.5rem;
        }
        
        .summary-card {
            overflow: hidden;
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }
        
        .summary-card:hover {
            transform: translateY(-2px);
            box-shadow: var(--box-shadow-hover);
        }
        
        .card-header { 
            background: var(--light-bg); 
            padding: 1.5rem; 
            border-bottom: 1px solid var(--border-color);
            display: flex;
            align-items: center;
            justify-content: space-between;
        }
        
        .card-title {
            display: flex;
            align-items: center;
            gap: 1rem;
        }
        
        .ticker { 
            font-weight: 700; 
            font-size: 1.25rem; 
            color: var(--card-bg);
            padding: 0.5rem 1rem;
            background: var(--primary-color);
            border-radius: 4px;
        }
        
        .time { 
            color: var(--accent-color); 
            font-size: 0.9rem;
            font-weight: 500;
        }
        
        .price-sensitive { 
            color: var(--primary-color);
            font-size: 1rem;
            margin-left: 0.5rem;
        }
        
        .card-body { 
            padding: 1.5rem; 
        }
        
        /* Summary content styles */
        .summary-content { 
            line-height: 1.7; 
            margin-bottom: 1rem;
            font-size: 1rem;
        }

        .summary-content h3 {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--primary-color);
            margin: 1rem 0 0.5rem 0;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.25rem;
        }

        .summary-content h3:first-child {
            margin-top: 0;
        }

        .summary-content h4 {
            font-size: 1rem;
            font-weight: 600;
            color: var(--secondary-color);
            margin: 0.75rem 0 0.25rem 0;
        }

        .summary-content hr {
            border: none;
            border-top: 1px solid var(--border-color);
            margin: 1.5rem 0;
        }

        .summary-content p {
            margin: 0.75rem 0;
        }

        .summary-content p:first-child {
            margin-top: 0;
        }

        .summary-content p:last-child {
            margin-bottom: 0;
        }

        .summary-content ul,
        .summary-content ol {
            margin: 0.5rem 0;
            padding-left: 1.5rem;
        }

        .summary-content li {
            margin: 0.25rem 0 0.75rem 0;
        }

        .summary-content ol li {
            margin-bottom: 0.75rem;
        }

        .summary-content ul ul,
        .summary-content ol ul,
        .summary-content ul ol,
        .summary-content.ol ol {
            margin: 0.25rem 0;
        }

        .summary-content li > ul,
        .summary-content li > ol {
            margin-top: 0.5rem;
        }

        .summary-content strong {
            font-weight: 600;
            color: var(--primary-color);
        }

        .summary-content em {
            font-style: italic;
            color: var(--accent-color);
        }
        
        .summary-meta { 
            display: flex; 
            align-items: center;
            gap: 1rem;
            padding-top: 1rem;
            border-top: 1px solid var(--border-color);
            font-size: 0.85rem;
            color: var(--accent-color);
        }
        
        .pdf-link { 
            color: var(--primary-color); 
            text-decoration: none; 
            font-weight: 500;
            padding: 0.25rem 0.75rem;
            border: 1px solid var(--primary-color);
            border-radius: 4px;
            transition: all 0.3s ease;
        }
        
        .pdf-link:hover { 
            background: var(--primary-color);
            color: var(--card-bg);
        }
        
        .no-data { 
            text-align: center; 
            padding: 4rem 2rem; 
            color: var(--accent-color);
        }
        
        .no-data h3 {
            font-size: 1.5rem;
            margin-bottom: 0.5rem;
            color: var(--primary-color);
        }
        
        .footer {
            margin-top: 3rem;
            padding: 2rem;
            text-align: center;
            color: var(--accent-color);
            font-size: 0.9rem;
        }
        
        .api-link {
            color: var(--primary-color);
            text-decoration: none;
            font-weight: 500;
            border-bottom: 1px solid transparent;
            transition: border-color 0.3s ease;
        }
        
        .api-link:hover {
            border-bottom-color: var(--primary-color);
        }
        
        .filter {
            padding: 1rem;
            margin-bottom: 2rem;
            text-align: center;
        }

        .filter label {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            cursor: pointer;
            color: var(--primary-color);
            font-size: 0.95rem;
        }

        .hidden {
            display: none;
        }
        
        @media (max-width: 768px) {
            .container {
                padding: 1rem;
            }
            
            .header {
                padding: 1.5rem;
            }
            
            .header h1 {
                font-size: 2rem;
            }
            
            .meta {
                flex-direction: column;
                gap: 0.5rem;
            }
            
            .card-header {
                flex-direction: column;
                align-items: flex-start;
                gap: 0.75rem;
            }
            
            .summary-meta {
                flex-direction: column;
                align-items: flex-start;
                gap: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>ASX Announcement Summaries</h1>
            <i class="fas fa-robot"></i>
            <div class="meta">
                <span>1 August 2025 • 3 announcements</span>
            </div>
        </div>

        <div class="filter">
            <label>
                <span class="price-sensitive">
                    <i class="fas fa-dollar-sign"></i>
                </span>
                <input type="checkbox" id="priceFilter">
            </label>
        </div>

        <div class="summary-grid">
            
                
                <div class="summary-card">
                    <div class="card-header">
                        <div class="card-title">
                            <span class="ticker">AFP</span>
                            <span class="time">
                                <i class="far fa-clock" style="margin-right: 0.25rem;"></i>
                                07:30
                            </span>
                            
                        </div>
                    </div>
                    <div class="card-body">
                        <div class="summary-content">
                            <ul>
<li><strong>FY26 operating profit guidance</strong>: $20.0 to $24.0 million.  </li>
<li><strong>Revenue target for FY27</strong>: $300 million.  </li>
<li><strong>R&amp;D pipeline</strong>: Targets addressable markets worth over <strong>US$8 billion</strong>, with 8 patented products and 24 off-patent injectables in development.  </li>
<li><strong>Key commercialisation programs</strong>: Maxigesic®, Crystaderm®, Micolette®, Kiwisoothe®, and capsaicin cream.  </li>
</ul>
<p><em>No material capital markets or trading-specific actions identified (e.g., capital raising, trading halt).</em></p>
                        </div>
                        <div class="summary-meta">
                            <span>
                                <i class="fas fa-file-alt" style="margin-right: 0.25rem;"></i>
                                2 pages
                            </span>
                            <span>
                                <i class="fas fa-brain" style="margin-right: 0.25rem;"></i>
                                1194 tokens
                            </span>
                            
                            <a href="https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975666" target="_blank" class="pdf-link">
                                <i class="fas fa-external-link-alt" style="margin-right: 0.25rem;"></i>
                                View PDF
                            </a>
                            
                        </div>
                    </div>
                </div>
                
                <div class="summary-card">
                    <div class="card-header">
                        <div class="card-title">
                            <span class="ticker">AFP</span>
                            <span class="time">
                                <i class="far fa-clock" style="margin-right: 0.25rem;"></i>
                                07:30
                            </span>
                            
                        </div>
                    </div>
                    <div class="card-body">
                        <div class="summary-content">
                            <ul>
<li><strong>Revenue milestone</strong>: Achieved record sales of $208 million (first time exceeding $200 million).  </li>
<li><strong>Geographic expansion</strong>: Launched Maxigesic IV and Combogesic Rapid in the US; began sales of Maxigesic IV in Canada (addressable market &gt;US$8 billion).  </li>
<li><strong>Financials</strong>: Net debt reduced to $14.5 million (from $16.2 million); dividend increased to 1.8 cents/share (from 1.6 cents).  </li>
<li><strong>R&amp;D pipeline</strong>: 8 patented products in development, 24 off-patent injectables, and 5 programs nearing commercialization (e.g., Maxigesic variants, Crystaderm).  </li>
<li><strong>FY27 target</strong>: Ambitious $300 million revenue goal.  </li>
</ul>
<p><em>Note: No capital markets actions (e.g., raising, halt) or urgent trading signals identified.</em></p>
                        </div>
                        <div class="summary-meta">
                            <span>
                                <i class="fas fa-file-alt" style="margin-right: 0.25rem;"></i>
                                4 pages
                            </span>
                            <span>
                                <i class="fas fa-brain" style="margin-right: 0.25rem;"></i>
                                2168 tokens
                            </span>
                            
                            <a href="https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975667" target="_blank" class="pdf-link">
                                <i class="fas fa-external-link-alt" style="margin-right: 0.25rem;"></i>
                                View PDF
                            </a>
                            
                        </div>
                    </div>
                </div>
                
                <div class="summary-card">
                    <div class="card-header">
                        <div class="card-title">
                            <span class="ticker">AFP</span>
                            <span class="time">
                                <i class="far fa-clock" style="margin-right: 0.25rem;"></i>
                                07:30
                            </span>
                            
                        </div>
                    </div>
                    <div class="card-body">
                        <div class="summary-content">
                            <p><strong>Summary of AFT Pharmaceuticals 2025 Annual Shareholders' Meeting Announcement</strong>  </p>
<h3><strong>Financial &amp; Operational Highlights</strong></h3>
<ul>
<li><strong>FY25 Revenue</strong>: NZ$208.0M (6% YoY growth), with ANZ sales at NZ$180.9M.  </li>
<li><strong>FY27 Target</strong>: Revenue of NZ$300M.  </li>
<li><strong>Operating Profit</strong>: NZ$17.6M (down from NZ$24.2M in FY24 due to lower licensing income and strategic investments).  </li>
<li><strong>Dividend</strong>: Increased to 1.8 cents per share (from 1.6 cps in FY24).  </li>
<li><strong>Net Debt</strong>: NZ$14.5M (down from NZ$16.2M in FY24).  </li>
<li><strong>R&amp;D Spend</strong>: NZ$15.0M (FY25), focused on 8 patented products and 24+ injectables.  </li>
</ul>
<h3><strong>Market Expansion &amp; Strategy</strong></h3>
<ul>
<li><strong>Global Reach</strong>: Products sold in ~80 countries; distribution agreements in 100+ countries.  </li>
<li><strong>Key Markets</strong>: Growth in Australasia (NZ: NZ$53.8M; Australia: NZ$127.1M), hampered by disruptions in Asia (NZ$15.4M, down from NZ$19.3M).  </li>
<li><strong>New Hubs</strong>: Launches in EU, UK, USA, Canada, South Africa, Hong Kong, and Singapore, with pipelines of 17–40 products per region.  </li>
</ul>
<h3><strong>R&amp;D Pipeline Highlights</strong></h3>
<ul>
<li><strong>Near-Term</strong>: 24 hospital injectables (filing 2025–2027), Migraine project (filing 1Q27), Pascomer (PWS treatment, filing 2027).  </li>
<li><strong>Long-Term</strong>: Antibiotic eye drop (2028), Keloid scar topical (2029), Burning Mouth Syndrome (2030).  </li>
</ul>
<h3><strong>Governance Resolutions</strong></h3>
<ol>
<li>Auditor remuneration approval (Deloitte).  </li>
<li>Re-election of Dr. Hartley Atkinson as Director.  </li>
<li>Election of Allison Yorston as Director.  </li>
</ol>
<h3><strong>Outlook</strong></h3>
<ul>
<li><strong>FY26 Operating Profit Guidance</strong>: NZ$20M–NZ$24M.  </li>
<li>Focus on product launches, international growth, and R&amp;D commercialization.  </li>
</ul>
<p><strong>Omitted</strong>: Director names, boilerplate, historical background, and non-material operational details.</p>
                        </div>
                        <div class="summary-meta">
                            <span>
                                <i class="fas fa-file-alt" style="margin-right: 0.25rem;"></i>
                                30 pages
                            </span>
                            <span>
                                <i class="fas fa-brain" style="margin-right: 0.25rem;"></i>
                                6352 tokens
                            </span>
                            
                            <a href="https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975668" target="_blank" class="pdf-link">
                                <i class="fas fa-external-link-alt" style="margin-right: 0.25rem;"></i>
                                View PDF
                            </a>
                            
                        </div>
                    </div>
                </div>
                
            
        </div>
        
        <div class="footer">
            <p>
                <i class="fas fa-chart-line" style="margin-right: 0.5rem;"></i>
                Dashboard updated automatically • 
                <a href="api.json" class="api-link">
                    <i class="fas fa-code" style="margin-right: 0.25rem;"></i>
                    JSON API
                </a>
            </p>
            <p style="margin-top: 0.5rem; font-size: 0.8rem; opacity: 0.7;">
            Not financial advice. Auto-generated content may contain errors.
            </p>
        </div>
    </div>

    <script>
        document.getElementById('priceFilter').addEventListener('change', function() {
            const cards = document.querySelectorAll('.summary-card');
            cards.forEach(card => {
                if (this.checked && !card.classList.contains('price-sensitive-card')) {
                    card.classList.add('hidden');
                } else {
                    card.classList.remove('hidden');
                }
            });
        });
    </script>
</body>
</html>